COURTNEY MANKIN: Open Payments
NPI 1407501984 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,049 in 56 payments from 19 companies in 2025. Trend: 2023 $619 · 2024 $331 · 2025 $1,049
Food & beverage: $1,049
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 4 | $161 |
| Lilly USA, LLC | 9 | $142 |
| ABBVIE INC. | 10 | $138 |
| Otsuka America Pharmaceutical, Inc. | 4 | $118 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $71 |
| AstraZeneca Pharmaceuticals LP | 4 | $67 |
| Kestra Medical Technology Services, Inc. | 2 | $60 |
| Phathom Pharmaceuticals, Inc. | 5 | $41 |
| Novo Nordisk Inc | 2 | $37 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $33 |
Products named: FREESTYLE LIBRE 3, REXULTI, QULIPTA, KISUNLA, TRINTELLIX, Assure WCD, MOUNJARO, AIRSUPRA.
Industry payments across LA — which companies pay providers there.
